Tivic Health Systems (NASDAQ:TIVC) Director Sheryle Bolton Purchases 10,000 Shares of Stock

Tivic Health Systems, Inc. (NASDAQ:TIVC) Director Sheryle Bolton acquired 10,000 shares of the stock in a transaction that occurred on Wednesday, April 15th. The stock was purchased at an average price of $1.04 per share, with a total value of $10,400.00. Following the transaction, the director owned 10,000 shares in the company, valued at $10,400. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Tivic Health Systems Price Performance

TIVC opened at $1.13 on Tuesday. The company has a quick ratio of 20.13, a current ratio of 20.13 and a debt-to-equity ratio of 0.38. Tivic Health Systems, Inc. has a 12 month low of $0.72 and a 12 month high of $13.23. The company has a fifty day simple moving average of $0.92 and a 200 day simple moving average of $1.58. The stock has a market cap of $3.25 million, a P/E ratio of -0.17 and a beta of 1.84.

Tivic Health Systems (NASDAQ:TIVC) last issued its quarterly earnings data on Monday, March 30th. The company reported ($1.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($408.00) by $406.97.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Tivic Health Systems in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Tivic Health Systems currently has a consensus rating of “Sell”.

About Tivic Health Systems

Tivic Health Systems is a commercial-stage medical technology company that develops and markets non-drug, neuromodulation-based therapies for nasal and sinus health. The company’s solutions are designed to alleviate sinus pain, pressure and congestion through gentle microcurrent and vibration stimulation. By targeting the underlying nerve pathways in the nasal passages, Tivic Health aims to provide an alternative to over-the-counter and prescription medications without introducing systemic side effects.

The flagship product, ClearUP™ Sinus Pain Relief, is an FDA-cleared, hand-held device intended for home use.